Jennifer Queally | Medical Services
Programs & Services
Jennifer Queally | Education
Undergraduate School
George Washington University
1998, Washington, DC
Graduate School
Clinical Psychology
Suffolk University
2003, Boston, MA
Internship
Psychology
Children's Hospital and Clinics
2003, Minneapolis, MN
Fellowship
Pediatrics Neuropsychology
Boston Children's Hospital
2005, Boston, MA
Jennifer Queally | Professional History
Jennifer Turek Queally, PhD, is a neuropsychologist who sees patients in Boston Children’s Spina Bifida Program and the Neuropsychology Program. She also has clinical and research interests in the transition into adulthood and self regulation/executive functioning skill development. Dr. Queally is a supervisor in the predoctoral internship program and the neuropsychology postdoctoral residency program. She completed her fellowship in pediatric neuropsychology at Boston Children's in 2005 and is an Assistant Professor of Psychology at Harvard Medical School.
Although Dr. Queally worked closely with oncology patients for years, much of her clinical work has now transitioned to be with children who have neurodevelopmental disorders; many of her current patients were born with a medical condition or were affected shortly after birth, changing their developmental trajectory. She has a strong interest in facilitating functional independence; each child deserves to have a team working with them to help support their development over time and to reach their potential. She is honored to be included in the teams of so many of our patients.
Jennifer Queally | Publications
Neurodevelopmental Implications on Urological Self-management Among People Living With Spina Bifida: A Practical Guide for Urology Providers. Urology. 2023 03; 173:17-25. View Neurodevelopmental Implications on Urological Self-management Among People Living With Spina Bifida: A Practical Guide for Urology Providers. Abstract
Improving Infant Hydrocephalus Outcomes in Uganda: A Longitudinal Prospective Study Protocol for Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure after ETV/CPC. Metabolites. 2022 Jan 14; 12(1). View Improving Infant Hydrocephalus Outcomes in Uganda: A Longitudinal Prospective Study Protocol for Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure after ETV/CPC. Abstract
Neuropsychological care guidelines for people with spina bifida. J Pediatr Rehabil Med. 2020; 13(4):663-673. View Neuropsychological care guidelines for people with spina bifida. Abstract
Validation of a bowel dysfunction instrument for adolescents with spina bifida. J Pediatr Urol. 2015 Aug; 11(4):199.e1-7. View Validation of a bowel dysfunction instrument for adolescents with spina bifida. Abstract
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis. Pediatr Blood Cancer. 2012 May; 58(5):758-65. View Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis. Abstract
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Pediatr Blood Cancer. 2011 Sep; 57(3):492-8. View Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Abstract
Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol. 2007 Nov 01; 25(31):4914-21. View Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. Abstract
Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy therapy compared with 18 gray cranial radiation as CNS treatment in Acute Lymphoblastic Leukemia: Findings from Dana Farber Cancer Institute ALL Consortium Protocol 95-01. Journal of Clinical Oncology. 2007; 25(31):4914-4921.